Methylsulfomycin I, a New Cyclic Peptide Antibiotic from a Streptomyces Sp. HIL Y-9420704
Overview
Affiliations
Methylsulfomycin I (1) is a new cyclic peptide antibiotic isolated from the fermentation broth of a Streptomyces sp. HIL Y-9420704. Its structure was elucidated by NMR and GC-MS. The in vitro activity (MIC) against a wide range of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-, and teicoplanin-resistant strains, is described.
Sarmiento-Vizcaino A, Martin J, Ortiz-Lopez F, Reyes F, Garcia L, Blanco G Front Chem. 2022; 10:948795.
PMID: 36405319 PMC: 9669575. DOI: 10.3389/fchem.2022.948795.
Sarmiento-Vizcaino A, Martin J, Reyes F, Garcia L, Blanco G Front Microbiol. 2021; 12:773095.
PMID: 34858379 PMC: 8631523. DOI: 10.3389/fmicb.2021.773095.
Khodamoradi S, Hahnke R, Mast Y, Schumann P, Kampfer P, Steinert M Antonie Van Leeuwenhoek. 2021; 114(10):1483-1496.
PMID: 34355285 PMC: 8448680. DOI: 10.1007/s10482-021-01609-4.
Naturally Occurring Oxazole-Containing Peptides.
Mhlongo J, Brasil E, de la Torre B, Albericio F Mar Drugs. 2020; 18(4).
PMID: 32290087 PMC: 7231064. DOI: 10.3390/md18040203.
as a Prominent Resource of Future Anti-MRSA Drugs.
Mangzira Kemung H, Tan L, Khan T, Chan K, Pusparajah P, Goh B Front Microbiol. 2018; 9:2221.
PMID: 30319563 PMC: 6165876. DOI: 10.3389/fmicb.2018.02221.